Stem Cell Transplantation for Patients With Multiple Myeloma

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 12, 2011

Primary Completion Date

September 12, 2025

Study Completion Date

September 12, 2025

Conditions
Myeloma
Interventions
DRUG

G-CSF

G-CSF will be self-administered shot daily for 4 days pre-transplant. Up to 8 doses of G-CSF may be given. G-CSF will also be administered once daily under the skin beginning 5 days after your stem cell infusion until your white blood cell count is high enough

DRUG

Plerixafor

Plerixafor (self-administered shot)prior to the beginning of the stem cell collection. Up to 4 doses of plerixafor may be given.

PROCEDURE

Apheresis

Stem cell collection begins on day 5 and can last up to 3 days depending on the number collected.

DRUG

Melphalan

Melphalan chemotherapy 100mg/m2 for 2 days after your admission into the hospital for your ASCT procedure.

PROCEDURE

Stem cell re-infusion

Stem cells are thawed and reinfused back into the body via a catheter in the vein.

DRUG

Basiliximab

Basiliximab (20mg) given by IV infusion (through the vein) 20-30 minutes the day after ASCT.

DEVICE

CliniMACS CD25 microbeads and cell sorter

The stem cells collected during apheresis will be counted and treated with CD25 microbeads and processed by a special device called a CliniMACs machine which removes the regulatory T cells from you stem cell product.

Trial Locations (1)

60637

University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER